Tid Tittel Kategori Vedlegg
15.01.2026
12:22
Zelluna ASA: Approval and publication of prospectus - -
17.12.2025
17:26
Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World's First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours - -
17.12.2025
17:26
Zelluna har nådd en viktig milepæl og innleverer søknad om klinisk studie i Storbritannia for første studie på mennesker av ZI-MA4-1 (ZIMA-101), verdens første MAGE-A4-rettede TCR-NK celleterapi for solide kreftformer. - -
16.12.2025
12:36
Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World's First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours - -
12.12.2025
13:02
Zelluna Completes First GMP Batch of ZI-MA4-1, a Novel TCR-NK Cell Therapy, to Treat Patients in Upcoming First-in-Human Trial - -
09.12.2025
09:36
Zelluna ASA: Cancellation of subsequent repair offering - -
08.12.2025
18:36
Zelluna ASA - Mandatory notification of trade STORAKSJONÆR AKS
1
08.12.2025
13:52
Zelluna ASA: New share capital registered - -
28.11.2025
07:50
Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial Officer - -
27.11.2025
08:35
Zelluna ASA: Disclosure of large shareholding STORAKSJONÆR AKS -
25.11.2025
16:05
Zelluna ASA: Disclosure of large shareholding STORAKSJONÆR AKS -
25.11.2025
12:09
ZELLUNA ASA: DISCLOSURE OF LARGE SHAREHOLDING STORAKSJONÆR AKS -
25.11.2025
11:32
Zelluna ASA - Extraordinary General Meeting held on November 25, 2025 -
2
17.11.2025
10:33
Zelluna ASA: New share capital registered - -
04.11.2025
13:04
Zelluna ASA: Notice of extraordinary general meeting on 25 November 2025 -
1
04.11.2025
09:10
Zelluna ASA: Disclosure of large shareholding STORAKSJONÆR AKS -
04.11.2025
08:28
Zelluna ASA: Disclosure of large shareholding STORAKSJONÆR AKS -
04.11.2025
07:29
Zelluna ASA: Disclosure of large shareholding STORAKSJONÆR AKS -
04.11.2025
07:00
Zelluna ASA - Ex. date - -
04.11.2025
00:58
Zelluna ASA - Key information relating to subsequent offering - -
04.11.2025
00:35
Zelluna ASA - Mandatory notification of trade -
1
03.11.2025
23:52
Zelluna ASA - Successful private placement and retail offering -
1
03.11.2025
16:47
Zelluna ASA - Contemplates private placement - -
03.11.2025
16:39
Zelluna ASA Reports Third Quarter 2025 Financial Results and Provides General Business Update -
1
09.10.2025
07:58
Zelluna Receives Positive MHRA Feedback and Strengthens UK Clinical Strategy for ZI-MA4-1 Paving the Way for First-in-Human Trials in the UK INFORMASJON INF -